# Capsaicin for Post-stroke Dysphagia

> **NCT04470752** · PHASE2 · UNKNOWN · sponsor: **Georg Kägi, MD** · enrollment: 82 (estimated)

## Conditions studied

- Dysphagia, Late Effect of Stroke

## Interventions

- **DRUG:** Capsaicin 1% oral solution
- **DRUG:** InOrpha Solution

## Key facts

- **NCT ID:** NCT04470752
- **Lead sponsor:** Georg Kägi, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-24
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04470752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04470752, "Capsaicin for Post-stroke Dysphagia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04470752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*